.Avidity Biosciences pleased financiers with phase 1/2 records in Duchenne muscle dystrophy (DMD) Fr...
.Actinogen Medical's cortisol blocker has actually skipped the primary endpoint of a phase 2 researc...
.Antibody-drug conjugates (ADCs) have actually been at the center of many a billion-dollar biobuck l...
.Property manager TPG, which has sustained biotechs like Sionna Therapeutics as well as Santa Clam A...
.Merck & Co.'s TIGIT course has suffered another misfortune. Months after shuttering a stage 3 ca...
.After a year specified by pipeline cuts, the departure of its own chief executive officer as well a...
.Cullinan Therapy was excited enough along with Harbour BioMed's bispecific immune system reactor th...
.In this particular full week's incident of "The Leading Pipe," our team're diving right into Fierce...
.The confetti is still soaring from Eli Lilly's party celebrating the approval of Alzheimer's condit...
.Welcome to this week's Chutes & Ladders, our summary of substantial management hirings, firings ...